BioFire Diagnostics, LLC recalls
BioFire Diagnostics, LLC is named on 17 recalls in Recall Relay's records since November 2023, from FDA (23 recalled products: FDA lists each product as its own recall); the most recent was August 12, 2026.
All 23 recalled products, newest first.
-
Class IIofficial
BioFire Diagnostics, LLC recalls Generic Name: FilmArray¿ Pneumonia Panel Generic Name: FilmArray¿ Pneumonia Panel Model/Catalog Number: RFIT-ADue to potential contaiminated of spefic lots of pneumonia and joint infection panels that could result in false positive results
-
Class IIofficial
BioFire Diagnostics, LLC recalls Generic Name: FilmArray¿ Pneumonia Panel plus Generic Name: FilmArray¿ Pneumonia Panel plus Model/Catalog NumbDue to potential contaiminated of spefic lots of pneumonia and joint infection panels that could result in false positive results
-
Class IIofficial
BioFire Diagnostics, LLC recalls Generic Name: BioFire¿ Joint Infection (JI) Panel Generic Name: BioFire¿ Joint Infection (JI) Panel Model/CataDue to potential contaiminated of spefic lots of pneumonia and joint infection panels that could result in false positive results
-
Class IIofficial
BioFire Diagnostics, LLC recalls BIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acid tDue to increase in false negative results
-
Class IIofficial
BioFire Diagnostics, LLC recalls BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138Contamination to in-vitro diagnostic test may result in false positives.
-
Class IIofficial
BioFire Diagnostics, LLC recalls Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485Respiratory/sore throat panel test may result in false negative results and control failures.
-
Class IIofficial
BioFire Diagnostics, LLC recalls BioFire Respiratory Panel 2.1Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures.
-
Class IIofficial
BioFire Diagnostics, LLC recalls BioFire Respiratory Panel 2.1 plus KitDue to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.
-
Class IIofficial
BioFire Diagnostics, LLC recalls FilmArra Pneumonia Panel plus (Pneumoplus)Increased risk of control failures and false negative test results with multiplexed nucleic acid test.
-
Class IIofficial
BioFire Diagnostics, LLC recalls FILMARRAY TORCH MODULE BOXSome automated in vitro diagnostic modules and instruments manufactured or serviced between May 2022 and May 2024 were calibrated with internal equipment that may lead modules and instruments to report higher melting temperatures, which may lead to erroneous results including false positive Salmonella, Giardia lamblia, false positive/negative Norovirus, and false negative MRSA.
-
Class IIofficial
BioFire Diagnostics, LLC recalls FILMARRAY 2.0 INSTRUMENTSome automated in vitro diagnostic modules and instruments manufactured or serviced between May 2022 and May 2024 were calibrated with internal equipment that may lead modules and instruments to report higher melting temperatures, which may lead to erroneous results including false positive Salmonella, Giardia lamblia, false positive/negative Norovirus, and false negative MRSA.
-
Class IIofficial
BioFire Diagnostics, LLC recalls BIOFIRE Blood Culture Identification 2 (BCID2) PanelIf blood culture identification panel is used in conjunction with specific lots of culture media bottles, then false positive Serratia marcescens results may occur, due to an increased level of non-viable organism from serratia marcescens targets in culture media bottles, false positive result may lead to an inappropriate change in patient therapy.
-
Class IIofficial
BioFire Diagnostics, LLC recalls BIOFIRE FILMARRAY Pneumonia PanelPneumonia panels have an increased risk of control failures due to an issue in the manufacturing process, which could lead to delayed results for the customer.
-
Class IIofficial
BioFire Diagnostics, LLC recalls BIOFIRE FILMARRAY Pneumonia Panel plusPneumonia panels have an increased risk of control failures due to an issue in the manufacturing process, which could lead to delayed results for the customer.
-
Class IIofficial
BioFire Diagnostics, LLC recalls BIOFIRE FILMARRAY Gastrointestinal (GI) Panel REF RFIT-ASY-0116 (30 test kit) BIOFIRE FILMARRAY GastrointestinDue to increase of false positive Vibrio/Vibrio Cholerae results when using a certain transport medium.
-
Class IIofficial
BioFire Diagnostics, LLC recalls BIOFIRE Blood Culture Identification 2 (BCID2) Panel when used with: BD BACTEC Lytic Anaerobic medium BD BACTEDue to a trend in false positive Candida tropicalis results on blood culture panel when using certain BD BACTEC vial mediums
-
Class IIofficial
BioFire Diagnostics, LLC recalls FilmArray Gastrointestinal (GI) Panel RFIT-ASY-0116 (30 test kit) RFIT-ASY-0104 (6 test kit) GastrointestinalDue to potential signals of increased false positive Norovirus results when using the gastrointestinal (GI) panel.
-
Class IIofficial
BioFire Diagnostics, LLC recalls FilmArray Pneumonia Panel (Pneumo)Their is a potential for false positive results when using Pneumonia panel.
-
Class IIofficial
BioFire Diagnostics, LLC recalls FilmArray Pneumonia Panel Plus (Pneumoplus)Their is a potential for false positive results when using Pneumonia panel.
-
Class IIofficial
BioFire Diagnostics, LLC recalls BIOFIRE FILMARRAY Gastrointestinal (GI) Panel is a qualitative multiplexed nucleic acid-based in vitro diagnosA manufacturing event may contribute to elevated rates of false negative results while using gastrointestinal panel and respiratory panel, which could lead to inappropriate antibiotic treatment, no treatment, delay of treatment, and may provide false assurance to someone with a true infection, delayed identification of an outbreak, and may result in additional transmission.
-
Class IIofficial
BioFire Diagnostics, LLC recalls The BIOFIRE Respiratory Panel 2.1 (RP2.1) is a PCR-based multiplexed nucleic acid test intended for use with tA manufacturing event may contribute to elevated rates of false negative results while using gastrointestinal panel and respiratory panel, which could lead to inappropriate antibiotic treatment, no treatment, delay of treatment, and may provide false assurance to someone with a true infection, delayed identification of an outbreak, and may result in additional transmission.
-
Class IIofficial
BioFire Diagnostics, LLC recalls FilmArray TORCH REF HTFA-ASY-0104. HTFA-ASY-0104 is the BIOFIRE TORCH Base which includes barcode scannerDue to an increased risk of degradation of the power entry switch resulting from arcing inside of the power switch that may result in carbon build-up on the switch contacts. The carbon build-up may lead to excess heating inside of the power switch, subsequently leading to deformation of the power switch case. The deformation can create an opportunity for a power switch electrical short. In addition to an electrical short, deformation may result in an open circuit causing the power switch to fail. This event would only occur after the product is in use.
-
Class IIofficial
BioFire Diagnostics, LLC recalls BIOFIRE Blood Culture Identification 2 (BCID2) PanelRoutine quality control testing of affected blood culture identification panel with affected control panel may need to be amended, due to control panel/instrument characteristic changes, that lead C. tropicalis to be amplified in some portion of test runs, but then it's reported as "Not Detected" because the assay amplicon Tm is outside the acceptable limit assigned for calling positive results.
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions BioFire Diagnostics, LLC or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts